Protective effects of Let-7a and Let-7b on oxidized low- density lipoprotein induced endothelial cell injuries

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Bao, Mei Hua ^a   Zhang, Yi Wen ^b,c   Lou, Xiao Ya ^b,c   Cheng, Yu ^b,c   Zhou, Hong Hao ^b,c  

^a CHANGSHA MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MICRORNA; MICRORNA LET 7A; MICRORNA LET 7B; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; LOW DENSITY LIPOPROTEIN; MIRNLET7 MICRORNA, HUMAN; NOS3 PROTEIN, HUMAN; OLR1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

3' UNTRANSLATED REGIONS; APOPTOSIS; BINDING SITES; ENDOTHELIAL CELLS; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MAP KINASE SIGNALING SYSTEM; MICRORNAS; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SCAVENGER RECEPTORS, CLASS E;

EID: 84907450617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106540     Document Type: Article

References (37)

1. Chen M, Masaki T, Sawamura T (2002) LOX-1, the receptor for oxidized lowdensity lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 95: 89-100.
2. Imanishi T, Hano T, Sawamura T, Takarada S, Nishio I (2002) Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells. Circ J 66: 1060-1064.
3. Jiang F, Gibson AP, Dusting GJ (2001) Endothelial dysfunction induced by oxidized low-density lipoproteins in isolated mouse aorta: a comparison with apolipoprotein-E deficient mice. Eur J Pharmacol 424: 141-149.
4. Ogura S, Kakino A, Sato Y, Fujita Y, Iwamoto S, et al. (2009) Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ J 73: 1993-1999.
5. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, et al. (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-77.
6. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, et al. (1999) Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99: 3110-3117.
7. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, et al. (2007) Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 100: 1634-1642.
8. Li D, Liu L, Chen H, Sawamura T, Mehta JL (2003) LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23: 816-821.
9. Lee WJ, Ou HC, Hsu WC, Chou MM, Tseng JJ, et al. (2010) Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg 52: 1290-1300.
10. Xu X, Gao X, Potter BJ, Cao JM, Zhang C (2007) Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Arterioscler Thromb Vasc Biol 27: 871-877.
11. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, et al. (2007) Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 100: 1634-1642.
12. Stein S, Matter CM (2011) Protective roles of SIRT1 in atherosclerosis. Cell Cycle 10: 640-647.
13. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, et al. (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906.
14. Bao MH, Feng X, Zhang YW, Lou XY, Cheng Y, et al. (2013) Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int J Mol Sci 14: 23086-23102.
15. Ding Z, Wang X, Schnackenberg L, Khaidakov M, Liu S, et al. (2013) Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g. Int J Cardiol 168: 1378-1385.
16. Satoh M, Minami Y, Takahashi Y, Tabuchi T, Nakamura M (2011) A cellular microRNA, let-7i, is a novel biomarker for clinical outcome in patients with dilated cardiomyopathy. J Card Fail 17: 923-929.
17. Chen KC, Hsieh IC, Hsi E, Wang YS, Dai CY, et al. (2011) Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1. J Cell Sci 124: 4115-4124.
18. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S (2007) Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101: 59-68.
19. Bao MH, Zhang YW, Zhou HH (2013) Paeonol suppresses oxidized low-density lipoprotein induced endothelial cell apoptosis via activation of LOX-1/ p38MAPK/NF-kB pathway. J Ethnopharmac 146: 543-551.
20. Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O (1998) Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J 334 (Pt 1): 9-13.
21. Yoshimoto R, Fujita Y, Kakino A, Iwamoto S, Takaya T, et al. (2011) The discovery of LOX-1, its ligands and clinical significance. Cardiovasc Drugs Ther 25: 379-391.
22. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME (2010) The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17: F19-F36.
23. Choy JC, Granville DJ, Hunt DW, McManus BM (2001) Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 33: 1673-1690.
24. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, et al. (1998) Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97: 2494-2498.
25. Celermajer DS (1997) Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 30: 325-333.
26. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, et al. (2000) Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest 105: 451-458.
27. Liao JK, Shin WS, Lee WY, Clark SL (1995) Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 270: 319-324.
28. Smirnova IV, Kajstura M, Sawamura T, Goligorsky MS (2004) Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation. Am J Physiol Heart Circ Physiol 287: H782-H790.
29. Li DY, Chen HJ, Mehta JL (2001) Statins inhibit oxidized-LDL-mediated LOX- 1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc Res 52: 130-135.
30. Ou HC, Song TY, Yeh YC, Huang CY, Yang SF, et al. (2010) EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1- mediated signaling. J Appl Physiol (1985) 108: 1745-1756.
31. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, et al. (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275: 12633-12638.
32. Vermeulen L, De Wilde G, Notebaert S, Vanden BW, Haegeman G (2002) Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol 64: 963-970.
33. Huang B, Yang XD, Lamb A, Chen LF (2010) Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. Cell Signal 22: 1282-1290.
34. Khan MS, Halagowder D, Devaraj SN (2011) Methylated chrysin induces coordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model. Chem Biol Interact 193: 12-21.
35. Ho FM, Lin WW, Chen BC, Chao CM, Yang CR, et al. (2006) High glucoseinduced apoptosis in human vascular endothelial cells is mediated through NFkappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/ eNOS pathway. Cell Signal 18: 391-399.
36. Du X, Stocklauser-Farber K, Rosen P (1999) Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic Biol Med 27: 752-763.
37. Robbesyn F, Salvayre R, Negre-Salvayre A (2004) Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 38: 541-551.